Mendlewicz J, Vanderheyden J E, Noel G
Adv Exp Med Biol. 1981;133:753-67. doi: 10.1007/978-1-4684-3860-4_42.
Probenecid was administered to 7 unipolar depressed patients, 7 parkinsonians and 7 extrapyramidal patients with senile dementia matched for age and sex. Before and after the administration of probenecid, the levels of 5 hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) were determined in the cerebrospinal fluid (CSF) of all patients in order to study the central turnover rate of serotonin and dopamine. Unipolar depressed patients showed a significantly lower increase in CSF 5HIAA levels after probenecid than parkinsonians. Patients with Parkinsonism had a reduced increment of CSF HVA levels following probenecid administration when compared to unipolar depressed and extrapyramidal patients with senile dementia.
丙磺舒被给予7名单相抑郁症患者、7名帕金森病患者和7名患有老年痴呆症的锥体外系疾病患者,这些患者在年龄和性别上相互匹配。在给予丙磺舒之前和之后,测定了所有患者脑脊液(CSF)中5-羟吲哚乙酸(5HIAA)和高香草酸(HVA)的水平,以研究血清素和多巴胺的中枢周转率。单相抑郁症患者在服用丙磺舒后,脑脊液中5HIAA水平的升高明显低于帕金森病患者。与单相抑郁症患者和患有老年痴呆症的锥体外系疾病患者相比,帕金森病患者在服用丙磺舒后脑脊液中HVA水平的升高幅度较小。